Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea
- PMID: 16886000
- DOI: 10.1038/sj.gt.3302826
Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea
Abstract
This study was designed to determine whether Coxsackie adenovirus receptor (CAR) and alpha nu beta3/alpha nu beta5 integrin co-receptors are involved in adenovirus gene transfer in the rat cochlea. We find that CAR and integrin co-receptors are expressed in every cell subtype transduced by the adenoviral vector Ad5 DeltaE1-E3/cytomegalovirus/green fluorescent protein (GFP) on cochlear slices in vitro. The spiral ganglion neurons, which do not express CAR, were not transduced by the virus. Blocking these receptors by monoclonal antibodies decreased transgene expression, whereas disrupting tight junctions with ethylenediaminetetraacetic acid led to an increased transgene expression. However, sensory hair cells and strial cells also expressing CAR and alpha nu integrins were not transduced by the vector. GFP expression was also studied in vivo. Perilymphatic perfusion of adenovirus in vivo did not affect hearing and only cells lining the perilymphatic spaces were transduced. Endolymphatic perfusion resulted in low-frequency hearing loss and although some cells of the organ of Corti were efficiently transduced, the sensory and the strial cells were not. Transduced sensory and strial cells were occasionally observed in cochleas after single shot of adenovirus. Pretreatment with anti-CAR and anti-alpha nu antibodies decreases GFP expression in vivo, suggesting that the CAR/alpha nu integrin pathway is involved in adenovirus transduction in the cochlea.
Similar articles
-
Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.Int J Oncol. 2008 Dec;33(6):1141-7. Int J Oncol. 2008. PMID: 19020746
-
Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.J Gene Med. 2001 Nov-Dec;3(6):550-9. doi: 10.1002/jgm.223. J Gene Med. 2001. PMID: 11778901
-
Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.Gene Ther. 1999 Sep;6(9):1520-35. doi: 10.1038/sj.gt.3301030. Gene Ther. 1999. PMID: 10490761
-
Cancer-targeting gene therapy using tropism-modified adenovirus.Anticancer Res. 2007 Nov-Dec;27(6A):3679-84. Anticancer Res. 2007. PMID: 17970028 Review.
-
Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies.Adv Otorhinolaryngol. 2009;66:87-98. doi: 10.1159/000218209. Epub 2009 Jun 2. Adv Otorhinolaryngol. 2009. PMID: 19494574 Review.
Cited by
-
Construction and application of adenoviral vectors.Mol Ther Nucleic Acids. 2023 Sep 9;34:102027. doi: 10.1016/j.omtn.2023.09.004. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37808925 Free PMC article. Review.
-
Neurotrophin gene therapy for sustained neural preservation after deafness.PLoS One. 2012;7(12):e52338. doi: 10.1371/journal.pone.0052338. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284995 Free PMC article.
-
Gene therapy for the inner ear.Hear Res. 2013 Mar;297:99-105. doi: 10.1016/j.heares.2012.11.017. Epub 2012 Dec 21. Hear Res. 2013. PMID: 23265411 Free PMC article. Review.
-
Adenoviral vectors for improved gene delivery to the inner ear.Hear Res. 2009 Feb;248(1-2):31-8. doi: 10.1016/j.heares.2008.11.009. Epub 2008 Dec 7. Hear Res. 2009. PMID: 19105978 Free PMC article.
-
Emerging Gene Therapies for Genetic Hearing Loss.J Assoc Res Otolaryngol. 2017 Oct;18(5):649-670. doi: 10.1007/s10162-017-0634-8. Epub 2017 Aug 16. J Assoc Res Otolaryngol. 2017. PMID: 28815315 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials